MI: Mycobacterial Diseases Flashcards

1
Q

How can mycobacteria be categorised?

A

Rapid-growing and slow-growing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List three types of mycobacterial complex.

A

Mycobacterium tuberculosis complex

  • Mycobacterium tuberculosis
  • Mycobacterium bovis

Mycobacterium avium complex

  • Mycobacterium avium
  • Mycobacterium intracellulare

Mycobacterium abscessus complex

  • Mycobacterium abscessus
  • Mycobacterium massiliense
  • Mycobacterium bolletii
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the morphology of mycobacteria.

A
  • Non-motile rod-shaped bacteria
  • Relatively slow-growing
  • Cell wall composed of mycolic acids, complex waxes and glycoproteins
  • Acid-alcohol fast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is used as a screening test for mycobacterial infections?

A

Auramine stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How are non-tuberculous mycobacterial infections transmitted?

A
  • NOT person-to-person
  • From the environment
  • May be colonising rather than infecting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List three examples of slow-growing non-tuberculous mycobacteria and the diseases that they cause.

A

Mycobacterium avium intracellulare

  • May invade bronchial tree or pre-existing bronchiectasis/cavaties
  • Disseminated infection in immunocompromised patients

Mycobacterium marinum

  • Swimming pool granuloma

Mycobacterium ulcerans

  • Skin lesions (e.g. Bairnsdale ulcer, Buruli ulcer)
  • Chronic progressive painless ulcer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List three examples of rapid-growing non-tuberculous mycobacteria.

A
  • Mycobacterium abscessus
  • Mycobacterium chelonae
  • Mycobacterium fortuitum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List some risk factors for NTM.

A

Age

Underlying lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is Mycobacterium avium intracellulare treated?

A
  • Clarthromycin/azithromycin
  • Rifampicin
  • Ethambutol
  • +/- streptomycin/amikacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two types of Mycobacterium leprae infection?

A
  • Paucibacillary tuberculoid - few skin lesions, robust T cell response
  • Multibacillary lepromatous - multiple skin lesions, poor T cell response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most common cause of death by infectious agent in the world?

A
  • 1 = HIV
  • 2 = TB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How many species are part of the Mycobacterium tuberculosis complex?

A

7 (including Mycobacterium tuberculosis, bovix and africanum)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the generation time of Mycobacterium tuberculosis?

A

15-20 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the infectious dose of Mycobacterium tuberculosis?

A

1-10 bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the natural history of primary TB.

A
  • Usually asymptomatic
  • Ghon focus (granuloma in the lungs)
  • Controlled by cell-mediated immunity
  • Occasionally causes diseeminated/military TB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is post-primary TB?

A

Reactivation or exogenous re-infection

Happens > 5 years after primary infection

17
Q

List some risk factors for reactivation of TB.

A
  • Immunosuppression
  • Chronic alcohol excess
  • Malnutrition
  • Ageing
18
Q

List some types of extra-pulmonary TB.

A
  • Lymphadenitis (scrofula) - cervical lymph nodes most commonly
  • Gastrointestinal - due to swallowing of tubercle
  • Peritoneal - ascitic or adhesive
  • Genitourinary
  • Bone and joint - due to haematogenous spread (e.g. Pott’s disease)
  • Miliary TB
  • Tuberculous meningitis
19
Q

Why is it important to take 3 sputum samples when investigating suspected TB?

A

Increases the sensitivity of the smear microscopy

20
Q

What investigation may be done in children with suspected TB?

A

Gastric aspirate

21
Q

What is the turnaround time for smear microscopy and PCR?

22
Q

What is the issue with culturing TB?

A

It takes up to 6 weeks

23
Q

What is the histological hallmark of TB?

A

Caseating granulomas

24
Q

What is NAAT and why is it useful?

A
  • Nucleic acid amplification test
  • Allows speciation and the detection of drug resistance mutations
  • Rapid
25
What is the tuberculin skin test?
A sample of tuberculin is injected intradermally and left for 48-72 hours to observe the response
26
What are the disadvantages of the tuberculin skin test?
* Cross-reacts with BCG * Cannot distinguish between active and latent TB
27
What is an IGRA assay?
* Detection of antigen-specific IFN-gamma production * Does NOT cross-react with BCG * However, it cannot distinguish between latent and active TB
28
List some side-effects of: 1. Rifampicin 2. Isoniazid 3. Pyrazinamide 4. Ethambutol
1. **Rifampicin** * Raised transaminases * CYP450 induction * Orange secretions 2. **Isoniazid** * Peripheral neuropathy (give with pyridoxine) * Hepatotoxicity 3. **Pyrazinamide** * Hepatotoxicity 4. **Ethambutol** * Visual disturbance
29
Describe the treatment regimen for TB.
* RIPE for 2 months * Followed by rifampicin and isoniazid for 4 more months
30
What is DOT?
Direct observation therapy
31
What is multi-drug resistant TB?
Resistant to rifampicin and isoniazid
32
What is extremely drug resistant TB?
Resistant to rifampicin, isoniazid, fluoroquinolones and at least 1 injectable
33
What are the diagnostic challenges of HIV and TB coinfection?
* Clinical presentation is less likely to be classical * Symptoms may be absent if CD4+ count is low * More likely to have extra-pulmonary manifestations * Tuberculin skin test more likely to give false-negative * Low sensitivity for IGRAs
34
What are the treatment challenges of HIV and TB coinfection?
* Timing of treatment * Drug interactions * Overlapping toxicities * Duration of treatment